Abstract
An integrated care pathway is proposed for idiopathic intracranial hypertension, a condition which may result in permanent visual impairment or loss in young people. This proposal is prompted by the ‘boundary’ nature of the condition, which transcends traditional professional categories and hence involves a wide array of professional groups in patient management from both primary and secondary care, and also by the absence of sufficient information from clinical trials to permit an evidence-based management strategy. An integrated care pathway may not only optimize current best practice but also facilitate patient recruitment for randomized controlled trials.
Get full access to this article
View all access options for this article.
